Lentiviruses
All BPS Bioscience Lentiviral products are supplied as ready-to-use viral particles. Uses include
- Stable cell line generation
- Protein expression or protein knockout
- Detection method for biochemical assays and reporter assays (GFP, luciferase)
BPS’s lentivirus are enveloped viruses that enter cells by membrane fusion. Our lentivirus have been VSV-G pseudotyped; this means that the virus consist of vector particles bearing glycoproteins derived from other enveloped viruses—in this case, vesicular stomatitis virus GP (VSV-G). VSV-G pseudotyping provides stability and a very broad host range, making these virus particles especially useful to target a wide range of cell types.
Lentivirus Advantages
- Can infect both actively-dividing and non-dividing cells, whereas most viruses can only infect mitotically-active cells
- Can infect a wide range of cell stages
- Ideal for transducing primary cells or stem cells, which can be resistant to other transduction methods
- Size of inserted DNA can be up to 10 kb
- Long-term stable expression of a transgene
- Low immunogenicity, low toxicity, and transduction efficiencies can be extremely high (up to 100%)
-
-
-
-
-
-
-
-
-
-
-
Secreted Gaussia Luciferase Lentivirus CMV Promoter or EF1A Promoter79892500 µl x 2As low as $795
-
Spike (B.1.1.529 BA.1, Omicron Variant) (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter)78349
100 µl
500 µl x 2
As low as $875 -
Spike (B.1.1.529 BA.1, Omicron Variant) (SARS-CoV-2) Pseudotyped Lentivirus (Luc Reporter)78348
100 µl
500 µl x 2
As low as $900 -
Spike (B.1.1.7, Alpha Variant) (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter)2 citations78158
100 µl
500 µl x2
As low as $835 -
Spike (B.1.1.7, Alpha Variant) (SARS-CoV-2) Pseudotyped Lentivirus (Luc Reporter)8 citations78112
100 µl
500 µl x2
As low as $875 -
Spike (B.1.351, Beta Variant) (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter)78160
100 µl
500 µl x2
As low as $835 -
Spike (B.1.351, Beta Variant) (SARS-CoV-2) Pseudotyped Lentivirus (Luc Reporter)8 citations78142
100 µl
500 µl x2
As low as $860 -
Spike (B.1.429, Epsilon Variant) Pseudotyped Lentivirus (Luc Reporter)78172
100 µl
500 µl x2
As low as $835 -
-
Spike (B.1.617.1, Kappa Variant) Pseudotyped Lentivirus (Luc Reporter)78205
100 µl
500 µl x 2
As low as $835 -
Spike (B.1.617.2.1; Delta Plus Variant) (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter)78219
100 µl
500 µl x 2
As low as $835 -
Spike (B.1.617.2.1; Delta Plus Variant) Pseudotyped Lentivirus (Luc Reporter)78218
100 µl
500 µl x 2
As low as $835 -
Spike (B.1.617.2; Delta Variant) (SARS-CoV-2) Pseudotyped Lentivirus (eGFP Reporter)4 citations78216
100 µl
500 µl x 2
As low as $860 -
Spike (B.1.617.2; Delta Variant) Pseudotyped Lentivirus (Luc Reporter)4 citations78215
100 µl
500 µl x 2
As low as $900 -